// App-Quantinova.ai

7092 : Circulating tumor cells (CTCs) in patients (pts) with small cell lung cancer (SCLC) as a marker of disease burden and therapeutic response, and predictor of disease relapse.

Researchers

Presenter

  • Anjana Ranganathan

Principal Investigators

  • Daniel Schwed-Lustgarten

  • Charu Aggarwal

  • Mark C. Connelly

  • Steven Albelda

  • Corey J. Langer

  • Lynn Werner

  • Drew A. Torigian

  • Andrea B. Troxel

  • Tracey L. Evans

  • James Stevenson

  • Roger B. Cohen

  • Bhavesh Vaidya

  • Chandra Rao

Medical Centers

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

  • University of Pennsylvania, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Small cell lung cancer

Biomarkers

  • Circulating tumor cells

  • Histone H2AX

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved